ARTICLE | Company News
CPMP positive on Glivec
July 27, 2001 7:00 AM UTC
The EU's Committee for Proprietary Medicinal Products (CPMP) issued a positive opinion for Glivec imatinib ( STI-571), a small molecule Bcr-Abl kinase inhibitor to treat chronic myeloid leukemia (CML)...